Omnicell, Inc. OMCL has witnessed strong momentum in the past year. Shares of the company have risen 41.6% against a 11.3% decline of the industry during the same time frame. The S&P 500 composite has ...

Omnicell , Inc. (NASDAQ:OMCL), a leading provider of medication management solutions in the healthcare technology sector, has been navigating a complex market environment characterized by both ...

Omnicell specializes in automated healthcare solutions, focusing on medication and supply management across the continuum of care. The company's market capitalization stood at approximately $1.85 ...

Shares of Omnicell, Inc. (NASDAQ:OMCL – Get Free Report) have received a consensus rating of “Hold” from the six ratings firms that are presently covering the stock, MarketBeat.com reports.

Importantly, our data indicates that Omnicell's profit was reduced by US$9.9m, due to unusual items, over the last year. It's never great to see unusual items costing the company profits ...

An illustration of a magnifying glass. An illustration of a magnifying glass.

Omnicell (OMCL) came out with quarterly earnings of $0.60 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.33 per share a year ago. These figures ...

OMNICELL ($OMCL) posted quarterly earnings results on Thursday, February 6th. The company reported earnings of $0.60 per share, beating estimates of $0.59 by $0.01 ...

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," "us," "management," or the "Company"), a leader in transforming the ...